Tripep Ab

David Van Der Spoel

Anders Vahlne

Laura Goobar-Larsson

Jin Su

Stefan H&ouml;glund

&Aacute;kos V&eacute;gv&aacute;ri

Sarah Sandin-Reneby

Csaba Het&eacute;nyi

Embodiments relate to the discovery that tripeptide amides, which correspond to viral capsid sequences, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising tripeptide amides and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.

Tripeptide amides that block viral infectivity and methods of use thereof

The present invention relates to the discovery that a specific pentamer peptide amide, which corresponds to a viral capsid sequence, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising said pentamer peptide amide and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.

Pentamer peptide amide, ALGPGNH2, which inhibits viral infectivity and methods of use thereof

The present invention relates to the discovery that a specific pentamer peptide amide, ALGPG-NH , which corresponds to a viral capsid sequence, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising said pentamer peptide amide and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.

Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof

Growing community of inventors

Uppsala, Sweden

David Van Der Spoel